Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080572 · ClinicalTrials.gov registry record
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 22
- Enrollment target
NCT02080572 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 22 participants.
The verdict
NCT02080572 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are made in the clinic. This study aims to quantitatively evaluate the effects of turning off deep brain stimulation on lower extremity and gait function over three hours. This study will provide vital information about our patient worn system's ability to detect changes in lower impairment over time, which could be used to assist with DBS tuning for the lower extremities and gait in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080572
The ClinicalTrials.gov registry entry for NCT02080572 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02080572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080572 about?
NCT02080572 is a clinical study titled "Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS". Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are mad...
What is the current status of trial NCT02080572?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2014-02.
Who is sponsoring clinical trial NCT02080572?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.